Brief: Tetra Bio-Pharma Enters Into Binding Proposal With Quantum Pharma Inc.
Nov 20 (Reuters) - Tetra Bio Pharma Inc TBP.V :
* TETRA BIO-PHARMA ENTERS INTO BINDING PROPOSAL WITH QUANTUM
PHARMA INC.
* TETRA BIO PHARMA INC - CO, QUANTUM PHARMA SIGNED BINDING
PROPOSAL FOR EXCLUSIVE ACCESS TO A HEALTH CANADA LICENSED
FACILITY FOR CANNABIS PRODUCTION
* TETRA BIO PHARMA INC - PROPOSED TRANSACTION TO ALSO
FABRICATE
CANNABINOID DRUG PRODUCTS FOR TETRA AND PANAG'S DEVELOPMENT
ACTIVITIES
Source text for Eikon: ID:nGNX8FGVmw
Further company coverage: TBP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding